Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 197950, 8 pages
http://dx.doi.org/10.1155/2015/197950
Review Article

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis

1Health Science Department, University of Milan Bicocca, AO San Gerardo, Via Pergolesi 33, 20052 Monza, Italy
2Department of Internal Medicine, Division of Infectious Diseases, AO San Gerardo, Via Pergolesi 33, 20052 Monza, Italy

Received 3 September 2014; Revised 10 December 2014; Accepted 12 December 2014

Academic Editor: Nikolaos Siafakas

Copyright © 2015 Giulia Bonaiti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. H. Runyon, “Anonymous mycobacteria in pulmonary disease,” The Medical Clinics of North America, vol. 43, no. 1, pp. 273–290, 1959. View at Google Scholar · View at Scopus
  2. J. M. Bryant, D. M. Grogono, D. Greaves et al., “Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study,” The Lancet, vol. 381, no. 9877, pp. 1551–1560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. W. M. Ricketts, T. C. O’Shaughnessy, and J. van Ingen, “Human-to-human transmission of Mycobacterium kansasii or victims of a shared source?” European Respiratory Journal, 2014. View at Publisher · View at Google Scholar
  4. D. R. Prevots, P. A. Shaw, D. Strickland et al., “Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 7, pp. 970–976, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Moore, M. E. Kruijshaar, L. P. Ormerod, F. Drobniewski, and I. Abubakar, “Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995–2006,” BMC Public Health, vol. 10, article 612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. D. S. Price, D. D. Peterson, R. M. Steiner et al., “Infection with Mycobacterium avium complex in patients without predisposing conditions,” The New England Journal of Medicine, vol. 321, no. 13, pp. 863–868, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Lee, K. S. Lee, J. W. Moon et al., “Nodular bronchiectatic Mycobacterium avium complex pulmonary disease: natural course on serial computed tomographic scans,” Annals of the American Thoracic Society, vol. 10, no. 4, pp. 299–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Thomson, J. G. Armstrong, and D. F. Looke, “Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease,” Chest, vol. 131, no. 4, pp. 1166–1172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Mirsaedi, W. Hadid, B. Ericsoussi et al., “NTM disease is common in patients with non cystic fibrosis bronchiectasis,” International Journal of Infectious Diseases, vol. 17, no. 11, pp. e1000–e1004, 2013. View at Google Scholar
  10. A. M. Middleton, M. V. Chadwick, A. G. Nicholson et al., “The role of Mycobacterium avium complex fibronectin attachment protein in adherence to the human respiratory mucosa,” Molecular Microbiology, vol. 38, no. 2, pp. 381–391, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. S. R. Krutzik and R. L. Modlin, “The role of Toll-like receptors in combating mycobacteria,” Seminars in Immunology, vol. 16, no. 1, pp. 35–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Vergne, S. Singh, E. Roberts et al., “Autophagy in immune defense against Mycobacterium tuberculosis,” Autophagy, vol. 2, no. 3, pp. 175–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Fulton, J. M. Johnsen, S. F. Wolf, D. S. Sieburth, and W. H. Boom, “Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis,” Infection and Immunity, vol. 64, no. 7, pp. 2523–2531, 1996. View at Google Scholar · View at Scopus
  14. M. K. Gately, L. M. Renzetti, J. Magram et al., “The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses,” Annual Review of Immunology, vol. 16, pp. 495–521, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kubo, Y. Yamazaki, M. Hanaoka et al., “Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 4, part 1, pp. 1368–1371, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Haverkamp, J. T. van Dissel, and S. M. Holland, “Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling,” Microbes and Infection, vol. 8, no. 4, pp. 1157–1166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Keane, “Tumor necrosis factor blockers and reactivation of latent tuberculosis,” Clinical Infectious Diseases, vol. 39, no. 3, pp. 300–302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. L. Winthrop, E. Chang, S. Yamashita, M. F. Iademarco, and P. A. LoBue, “Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy,” Emerging Infectious Diseases, vol. 15, no. 10, pp. 1556–1561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Renna, C. Schaffner, K. Brown et al., “Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection,” The Journal of Clinical Investigation, vol. 121, no. 9, pp. 3554–3563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. R. Horsburgh Jr., J. Gettings, L. N. Alexander, and J. L. Lennox, “Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985–2000,” Clinical Infectious Diseases, vol. 33, no. 11, pp. 1938–1943, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. S. D. Lawn, L.-G. Bekker, and R. F. Miller, “Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals,” The Lancet Infectious Diseases, vol. 5, no. 6, pp. 361–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Reich and R. E. Johnson, “Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome,” Chest, vol. 101, no. 6, pp. 1605–1609, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. R. D. Kim, D. E. Greenberg, M. E. Ehrmantraut et al., “Pulmonary nontuberculous mycobacterial disease : prospective study of a distinct preexisting syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 10, pp. 1066–1074, 2008. View at Publisher · View at Google Scholar
  24. T. Bienvenu, I. Sermet-Gaudelus, P.-R. Burgel et al., “Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 10, pp. 1078–1084, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. R. E. Colombo, S. C. Hill, R. J. Claypool, S. M. Holland, and K. N. Olivier, “Familial clustering of pulmonary nontuberculous mycobacterial disease,” Chest, vol. 137, no. 3, pp. 629–634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. D. Chan, A. M. Kaminska, W. Gill et al., “Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages,” Scandinavian Journal of Infectious Diseases, vol. 39, no. 8, pp. 690–696, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Suzuki, “Clinical comparison of pulmonary tuberculosis with pulmonary M. avium complex disease,” Kekkaku, vol. 70, no. 11, pp. 659–663, 1995. View at Google Scholar · View at Scopus
  28. V. Thanachartwet, V. Desakorn, D. Duangrithi et al., “Comparison of clinical and laboratory findings between those with pulmonary tuberculosis and those with nontuberculous mycobacterial lung disease,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 45, no. 1, pp. 85–94, 2014. View at Google Scholar · View at Scopus
  29. J. A. Queipo, E. Broseta, M. Santos, J. Sánchez-Plumed, A. Budía, and F. Jiménez-Cruz, “Mycobacterial infection in a series of 1261 renal transplant recipients,” Clinical Microbiology and Infection, vol. 9, no. 6, pp. 518–525, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Okumura, K. Iwai, H. Ogata et al., “Pulmonary Mycobacterium avium complex (MAC) disease showing middle lobe syndrome—pathological findings of 2 cases suggesting different mode of development,” Kekkaku, vol. 77, no. 9, pp. 615–620, 2002. View at Google Scholar · View at Scopus
  32. J. Fujita, Y. Ohtsuki, E. Shigeto et al., “Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex,” Respiratory Medicine, vol. 97, no. 8, pp. 933–938, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. F. Xu and H. Xiao, “Prevalence and clinical analysis of bronchiectasis with NTM lung disease in China,” Chest, vol. 145, no. 3, p. 429A, 2014. View at Publisher · View at Google Scholar
  34. S. J. Fowler, J. French, N. J. Screaton et al., “Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics,” European Respiratory Journal, vol. 28, no. 6, pp. 1204–1210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Seddon, K. Fidler, S. Raman et al., “Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009,” Emerging Infectious Diseases, vol. 19, no. 7, pp. 1128–1130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. M. Kilby, P. H. Gilligan, J. R. Yankaskas, W. E. Highsmith Jr., L. J. Edwards, and M. R. Knowles, “Nontuberculous mycobacteria in adult patients with cystic fibrosis,” Chest, vol. 102, no. 1, pp. 70–75, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. K. N. Olivier, D. J. Weber, R. J. Wallace Jr. et al., “Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 6, pp. 828–834, 2003. View at Publisher · View at Google Scholar
  38. J. A. Yu, M. Pomerantz, A. Bishop, M. J. Weyant, and J. D. Mitchell, “Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease,” European Journal of Cardio-Thoracic Surgery, vol. 40, no. 3, pp. 671–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. W.-J. Koh, K. S. Lee, O. J. Kwon, Y. J. Jeong, S.-H. Kwak, and T. S. Kim, “Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection,” Radiology, vol. 235, no. 1, pp. 282–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Wickremasinghe, L. J. Ozerovitch, G. Davies et al., “Non-tuberculous mycobacteria in patients with bronchiectasis,” Thorax, vol. 60, no. 12, pp. 1045–1051, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kunst, M. Wickremasinghe, A. Wells, and R. Wilson, “Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis,” European Respiratory Journal, vol. 28, no. 2, pp. 352–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Ferrara, S. Cappabianca, L. Brunese et al., “HRCT in detection of pulmonary infections from nontuberculous mycobacteria: personal experience,” Radiologia Medica, vol. 114, no. 3, pp. 376–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. R. J. Wallace Jr., J. L. Cook, J. Glassroth et al., “American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria,” American Journal of Respiratory and Critical Care Medicine, vol. 156, pp. S1–S25, 1997. View at Publisher · View at Google Scholar
  44. J. J. Erasmus, H. P. McAdams, M. A. Farrell, and E. F. Patz Jr., “Pulmonary nontuberculous mycobacterial infection: radiologic manifestations,” Radiographics, vol. 19, no. 6, pp. 1487–1505, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. C.-C. Shu, C.-H. Lee, C.-L. Hsu et al., “Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns,” Lung, vol. 189, no. 6, pp. 467–474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Zoumot, A. K. Boutou, S. S. Gill et al., “Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis,” Respirology, vol. 19, no. 5, pp. 714–722, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S. A. Evans, S. M. Turner, B. J. Bosch, C. C. Hardy, and M. A. Woodhead, “Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa,” European Respiratory Journal, vol. 9, no. 8, pp. 1601–1604, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. R. J. Wallace Jr., Y. Zhang, B. A. Brown et al., “Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis,” American Journal of Respiratory and Critical Care Medicine, vol. 158, no. 4, pp. 1235–1244, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Khan, A. Miller, M. Bachan, and J. Donath, “Mycobacterium avium complex (MAC) lung disease in two inner city community hospitals: recognition, prevalence, co-infection with mycobacterium tuberculosis (MTB) and pulmonary function (PF) improvements after treatment,” The Open Respiratory Medicine Journal, vol. 4, no. 1, pp. 76–81, 2010. View at Publisher · View at Google Scholar
  50. S. M. Hwang, M. S. Lim, Y. J. Hong et al., “Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens,” Tuberculosis, vol. 93, no. 6, pp. 642–646, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. F.-C. Bange, P. Kirschner, and E. C. Böttger, “Recovery of mycobacteria from patients with cystic fibrosis,” Journal of Clinical Microbiology, vol. 37, no. 11, pp. 3761–3763, 1999. View at Google Scholar · View at Scopus
  52. S. Y. Low, M. S. Koh, T. H. Ong et al., “Use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of granulomatous mediastinal lymphadenopathy,” Annals Academy of Medicine, vol. 43, no. 5, pp. 250–254, 2014. View at Google Scholar
  53. M. Slany and I. Pavlik, “Molecular detection of nontuberculous mycobacteria: advantages and limits of a broad-range sequencing approach,” Journal of Molecular Microbiology and Biotechnology, vol. 22, no. 4, pp. 268–276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. E. H. Moore, “Atypical mycobacterial infection in the lung: CT appearance,” Radiology, vol. 187, no. 3, pp. 777–782, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. K. McKlendin and P. Stark, “Mycobacterium avium intracellulare complex as a cause of bronchiectasis,” Seminars in Respiratory Infections, vol. 16, no. 1, pp. 85–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Woods, B. Brown-Elliott, and P. Conville, Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes, Clinical and Laboratory Standards Institute (CLSI), 2nd edition, 2011.
  57. D. E. Griffith and T. R. Aksamit, “Bronchiectasis and nontuberculous mycobacterial disease,” Clinics in Chest Medicine, vol. 33, no. 2, pp. 283–295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. R. J. Wallace Jr., B. A. Brown-Elliott, S. McNulty et al., “Macrolide/azalide therapy for nodular/bronchiectatic: MAC lung disease,” Chest, vol. 146, no. 2, pp. 276–282, 2014. View at Google Scholar
  59. R. J. Wallace Jr., Y. Zhang, B. A. Brown-Elliott et al., “Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis,” The Journal of Infectious Diseases, vol. 186, no. 2, pp. 266–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Kitada, T. Uenami, K. Yoshimura et al., “Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease,” International Journal of Tuberculosis and Lung Disease, vol. 16, no. 5, pp. 660–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Sato, T. Hiyama, K. Kaito, Y. Hayashi, and T. Okumura, “Usefulness of F-18 FDG PET/CT in the assessment of disseminated Mycobacterium avium complex infection,” Annals of Nuclear Medicine, vol. 23, no. 8, pp. 757–762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Drijkoningen, H. van der Pol, and M. de Vries, “PET scanning used for monitoring treatment response in Mycobacterium avium complex infection mimicking malignancy,” Clinical Nuclear Medicine, vol. 34, no. 11, pp. 818–820, 2009. View at Publisher · View at Google Scholar · View at Scopus